Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2

•Neurological complications related to SARS-CoV-2 are being reported around the world.•The more “rare” cases reported, causality and strong conclusions can be established.•Facial Diplegia and Guillain-Barré Syndrome have been connected to SARS-CoV-2 twice. We present a case of facial diplegia after...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of clinical neuroscience Ročník 77; s. 230 - 232
Hlavní autoři:	Juliao Caamaño, David Salomón, Alonso Beato, Rubén
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Scotland Elsevier Ltd 01.07.2020
Témata:	Betacoronavirus - pathogenicity Coronavirus Coronavirus Infections - complications Coronavirus Infections - virology COVID-19 Facial diplegia Facial nerve palsy Facial Paralysis - diagnosis Facial Paralysis - etiology Facial Paralysis - virology Guillain Barré Syndrome Guillain-Barre Syndrome - diagnosis Guillain-Barre Syndrome - etiology Guillain-Barre Syndrome - virology Humans Male Middle Aged Pandemics Pneumonia, Viral - complications Pneumonia, Viral - virology SARS-CoV-2 COVID-19 Guillain Barré Syndrome Facial diplegia SARS-CoV-2 Coronavirus Facial nerve palsy
ISSN:	0967-5868, 1532-2653, 1532-2653
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	•Neurological complications related to SARS-CoV-2 are being reported around the world.•The more “rare” cases reported, causality and strong conclusions can be established.•Facial Diplegia and Guillain-Barré Syndrome have been connected to SARS-CoV-2 twice. We present a case of facial diplegia after 10 days of SARS-CoV-2 confirmed infection symptoms in a 61 year old patient without prior clinically relevant background. There are few known cases of Guillain-Barré Syndrome (GBS) related to SARS-CoV-2 infection; we propose this case as a rare variant of GBS in COVID-19 infection context, due to Its chronology, clinical manifestations and cerebrospinal fluid (CSF) findings.
AbstractList	• Neurological complications related to SARS-CoV-2 are being reported around the world. • The more “rare” cases reported, causality and strong conclusions can be established. • Facial Diplegia and Guillain-Barré Syndrome have been connected to SARS-CoV-2 twice. We present a case of facial diplegia after 10 days of SARS-CoV-2 confirmed infection symptoms in a 61 year old patient without prior clinically relevant background. There are few known cases of Guillain-Barré Syndrome (GBS) related to SARS-CoV-2 infection; we propose this case as a rare variant of GBS in COVID-19 infection context, due to Its chronology, clinical manifestations and cerebrospinal fluid (CSF) findings. We present a case of facial diplegia after 10 days of SARS-CoV-2 confirmed infection symptoms in a 61 year old patient without prior clinically relevant background. There are few known cases of Guillain-Barré Syndrome (GBS) related to SARS-CoV-2 infection; we propose this case as a rare variant of GBS in COVID-19 infection context, due to Its chronology, clinical manifestations and cerebrospinal fluid (CSF) findings.We present a case of facial diplegia after 10 days of SARS-CoV-2 confirmed infection symptoms in a 61 year old patient without prior clinically relevant background. There are few known cases of Guillain-Barré Syndrome (GBS) related to SARS-CoV-2 infection; we propose this case as a rare variant of GBS in COVID-19 infection context, due to Its chronology, clinical manifestations and cerebrospinal fluid (CSF) findings. We present a case of facial diplegia after 10 days of SARS-CoV-2 confirmed infection symptoms in a 61 year old patient without prior clinically relevant background. There are few known cases of Guillain-Barré Syndrome (GBS) related to SARS-CoV-2 infection; we propose this case as a rare variant of GBS in COVID-19 infection context, due to Its chronology, clinical manifestations and cerebrospinal fluid (CSF) findings. •Neurological complications related to SARS-CoV-2 are being reported around the world.•The more “rare” cases reported, causality and strong conclusions can be established.•Facial Diplegia and Guillain-Barré Syndrome have been connected to SARS-CoV-2 twice. We present a case of facial diplegia after 10 days of SARS-CoV-2 confirmed infection symptoms in a 61 year old patient without prior clinically relevant background. There are few known cases of Guillain-Barré Syndrome (GBS) related to SARS-CoV-2 infection; we propose this case as a rare variant of GBS in COVID-19 infection context, due to Its chronology, clinical manifestations and cerebrospinal fluid (CSF) findings.
Author	Juliao Caamaño, David Salomón Alonso Beato, Rubén
Author_xml	– sequence: 1 givenname: David Salomón surname: Juliao Caamaño fullname: Juliao Caamaño, David Salomón email: davidsalomon.juliao@salud.madrid.org organization: Medical Resident at the Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain – sequence: 2 givenname: Rubén surname: Alonso Beato fullname: Alonso Beato, Rubén organization: Medical Resident at the Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/32410788$$D View this record in MEDLINE/PubMed
BookMark	eNqFkc9u1DAQxi1URLeFF-CAcuRAgu38cYIQUlnRglQJiQWulteZLLM4dmonKy1vxHPwYjjdFkEPRT7YGn-_bzTfnJAj6ywQ8pTRjFFWvdxmW6dtximnGS2zWHpAFqzMecqrMj8iC9pUIi3rqj4mJyFsKaVNkdNH5DjnBaOirhfkx7nSqEzS4mBgg-pFopLBhYBrA4ka9wPq-LtTHpUdE9clFxMao9Cmb5X3v34mq71tveujOETUKw-Jhck74zbXqHb9YOJrRGdnfnX2aZUu3deUPyYPO2UCPLm5T8mX83efl-_Ty48XH5Znl6kuBR9T1nWCFa0qqqbiZRy8FVzVPI7QCFVwplWU6abKu6YDliteVKIQrKnXzbpkuspPyZuD7zCte2g12NErIwePvfJ76RTKf38sfpMbt5OCc5aLOho8vzHw7mqCMMoeg4YYgwU3BckLGk_Bcxqlz_7u9afJbeBRUB8E2seUPXRS43gdTmyNRjIq593KrZx3K-fdSlrKWIoov4Peut8LvT5AEBPeIXgZNILV0KIHPcrW4f34qzu4NmjnxX6H_f_g37H20Y4
CitedBy_id	crossref_primary_10_1007_s13365_020_00912_6 crossref_primary_10_1007_s42399_020_00589_2 crossref_primary_10_1186_s12879_021_06185_6 crossref_primary_10_3390_life11020167 crossref_primary_10_1515_revneuro_2021_0148 crossref_primary_10_3390_medicina58080977 crossref_primary_10_1002_rmv_2345 crossref_primary_10_1590_1806_9282_67_2_20200716 crossref_primary_10_1002_jmv_26238 crossref_primary_10_1097_NRL_0000000000000342 crossref_primary_10_18502_jovr_v18i1_12731 crossref_primary_10_7759_cureus_42722 crossref_primary_10_1007_s10072_020_04693_y crossref_primary_10_1007_s10072_020_04801_y crossref_primary_10_1007_s42399_020_00646_w crossref_primary_10_1002_jmv_26121 crossref_primary_10_1016_j_heliyon_2022_e11328 crossref_primary_10_1016_j_tmaid_2021_102169 crossref_primary_10_1016_j_bbr_2024_114868 crossref_primary_10_1016_j_jns_2021_117316 crossref_primary_10_1007_s00415_020_09990_2 crossref_primary_10_1007_s10072_020_04708_8 crossref_primary_10_1016_j_autrev_2021_102875 crossref_primary_10_3892_etm_2021_10348 crossref_primary_10_1002_lary_30333 crossref_primary_10_1007_s11547_020_01311_x crossref_primary_10_1016_j_nrleng_2020_07_005 crossref_primary_10_1017_cjn_2021_102 crossref_primary_10_1212_WNL_0000000000010817 crossref_primary_10_1002_ccr3_3716 crossref_primary_10_1016_j_jocn_2021_06_016 crossref_primary_10_1111_ene_14493 crossref_primary_10_1111_jns_12482 crossref_primary_10_1007_s11356_021_14797_3 crossref_primary_10_1017_cjn_2021_108 crossref_primary_10_3389_fnagi_2021_653694 crossref_primary_10_1007_s00415_020_10124_x crossref_primary_10_1007_s13760_020_01421_3 crossref_primary_10_1016_j_fct_2020_111769 crossref_primary_10_1016_j_jns_2020_117085 crossref_primary_10_1016_j_cyto_2020_155404 crossref_primary_10_1007_s10072_020_04946_w crossref_primary_10_1097_MRM_0000000000000301 crossref_primary_10_1002_hsr2_887 crossref_primary_10_3390_biomedicines10030729 crossref_primary_10_1177_0333102420965963 crossref_primary_10_3389_fneur_2021_678136 crossref_primary_10_3390_neurolint14010003 crossref_primary_10_1007_s11910_021_01102_5 crossref_primary_10_1016_j_neurol_2020_10_001 crossref_primary_10_1111_ene_14462 crossref_primary_10_2147_EB_S268828 crossref_primary_10_1007_s00415_022_11050_w crossref_primary_10_3389_fneur_2020_566308 crossref_primary_10_3390_healthcare9111492 crossref_primary_10_3390_brainsci11101354 crossref_primary_10_1093_qjmed_hcab157 crossref_primary_10_1007_s10072_022_05982_4 crossref_primary_10_2174_1381612828666220506142117 crossref_primary_10_7759_cureus_22341 crossref_primary_10_1016_j_jaut_2020_102592 crossref_primary_10_1002_mus_27024 crossref_primary_10_1007_s10787_022_01047_2 crossref_primary_10_3390_vaccines9121502 crossref_primary_10_1016_j_jaut_2020_102506 crossref_primary_10_1159_000534250 crossref_primary_10_1136_jnnp_2020_324491 crossref_primary_10_3390_antiox10060971 crossref_primary_10_7759_cureus_17060 crossref_primary_10_1007_s00415_020_10014_2 crossref_primary_10_1007_s00415_023_11897_7 crossref_primary_10_1186_s41983_021_00435_9 crossref_primary_10_1111_ene_15371 crossref_primary_10_3389_fneur_2022_914411 crossref_primary_10_1093_qjmed_hcab188 crossref_primary_10_1016_j_ijid_2020_10_044 crossref_primary_10_1016_j_amjms_2022_04_010 crossref_primary_10_1016_j_lfs_2020_118568 crossref_primary_10_1097_WCO_0000000000001086 crossref_primary_10_1186_s13256_021_03120_w crossref_primary_10_1002_ana_26144 crossref_primary_10_1016_j_jneuroim_2020_577436 crossref_primary_10_1080_09273948_2021_1977829 crossref_primary_10_1016_j_ijid_2020_05_123
Cites_doi	10.1016/j.nrl.2020.03.001 10.1007/s00415-009-5254-8 10.1016/j.ncl.2013.01.005 10.1074/mcp.M115.056036 10.1016/j.jocn.2020.04.062 10.1016/j.nrl.2020.04.004 10.1016/j.idcr.2020.e00771 10.1016/j.bbi.2020.04.027 10.1056/NEJMc2009191 10.1176/jnp.7.2.125 10.1002/mus.24887
ContentType	Journal Article
Copyright	2020 Elsevier Ltd Copyright © 2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd
Copyright_xml	– notice: 2020 Elsevier Ltd – notice: Copyright © 2020 Elsevier Ltd. All rights reserved. – notice: 2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM
DOI	10.1016/j.jocn.2020.05.016
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1532-2653
EndPage	232
ExternalDocumentID	PMC7221378 32410788 10_1016_j_jocn_2020_05_016 S0967586820311012
Genre	Case Reports
GroupedDBID	--- --K --M -RU .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABJNI ABMAC ABMZM ABTEW ABWVN ABXDB ACDAQ ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRLJ AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDW HMK HMO HVGLF HZ~ IHE J1W KOM LX8 M29 M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SEL SES SEW SPCBC SSH SSN SSZ T5K UHS WUQ Z5R ~G- ~HD AACTN AADPK AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW LCYCR RIG 9DU AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM
ID	FETCH-LOGICAL-c572t-1ff714da469625101d72a8232497a421ca572c963f9fe13a246747198b9b51c63
ISICitedReferencesCount	76
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000542584900044&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0967-5868 1532-2653
IngestDate	Tue Sep 30 16:14:07 EDT 2025 Wed Oct 01 14:00:06 EDT 2025 Wed Feb 19 02:29:58 EST 2025 Tue Nov 18 21:51:49 EST 2025 Sat Nov 29 07:06:14 EST 2025 Fri Feb 23 02:47:15 EST 2024 Tue Oct 14 19:30:44 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Keywords	COVID-19 Guillain Barré Syndrome Facial diplegia SARS-CoV-2 Coronavirus Facial nerve palsy
Language	English
License	Copyright © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c572t-1ff714da469625101d72a8232497a421ca572c963f9fe13a246747198b9b51c63
Notes	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3
OpenAccessLink	https://pubmed.ncbi.nlm.nih.gov/PMC7221378
PMID	32410788
PQID	2404044230
PQPubID	23479
PageCount	3
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_7221378 proquest_miscellaneous_2404044230 pubmed_primary_32410788 crossref_citationtrail_10_1016_j_jocn_2020_05_016 crossref_primary_10_1016_j_jocn_2020_05_016 elsevier_sciencedirect_doi_10_1016_j_jocn_2020_05_016 elsevier_clinicalkey_doi_10_1016_j_jocn_2020_05_016
PublicationCentury	2000
PublicationDate	2020-07-01
PublicationDateYYYYMMDD	2020-07-01
PublicationDate_xml	– month: 07 year: 2020 text: 2020-07-01 day: 01
PublicationDecade	2020
PublicationPlace	Scotland
PublicationPlace_xml	– name: Scotland
PublicationTitle	Journal of clinical neuroscience
PublicationTitleAlternate	J Clin Neurosci
PublicationYear	2020
Publisher	Elsevier Ltd
Publisher_xml	– name: Elsevier Ltd
References	Wakerley, Yuki (b0030) 2015; 52 Marta-Enguita, Rubio-Baines, Gastón-Zubimendi (b0055) 2020 Camdessanche, Morel, Pozzetto, Paul, Tholance, Botelho-Nevers (b0060) 2020 Toscano, Palmerini, Ravaglia, Ruiz, Invernizzi, Cuzzoni (b0040) 2020 Ziganshin, Ivanova, Lomakin, Belogurov, Kovalchuk, Azarkin (b0050) 2016; 15 Dimachkie, Barohn (b0045) 2013; 31 Virani, Rabold, Hanson, Haag, Elrufay, Cheema (b0065) 2020 Sedaghat, Karimi (b0070) 2020 Matías-Guiu, Gómez-Pinedo, Montero-Escribano, Gómez-Iglesias, Porta-Etessam, Matías-Guiu (b0015) 2020 Wu, Xu, Chen, Duan, Hashimoto, Yang (b0010) 2020 Cheyette, Cummings (b0005) 1995; 7 Mao, Wang, Chen, He, Chang, Hong (b0025) 2020 Susuki, Koga, Hirata, Isogai, Yuki (b0035) 2009; 256 Zhao, Shen, Zhou, Liu, Chen (b0075) 2020; 4422 Troyer, Kohn, Hong (b0020) 2020 Toscano (10.1016/j.jocn.2020.05.016_b0040) 2020 Dimachkie (10.1016/j.jocn.2020.05.016_b0045) 2013; 31 Zhao (10.1016/j.jocn.2020.05.016_b0075) 2020; 4422 Ziganshin (10.1016/j.jocn.2020.05.016_b0050) 2016; 15 Camdessanche (10.1016/j.jocn.2020.05.016_b0060) 2020 Matías-Guiu (10.1016/j.jocn.2020.05.016_b0015) 2020 Sedaghat (10.1016/j.jocn.2020.05.016_b0070) 2020 Susuki (10.1016/j.jocn.2020.05.016_b0035) 2009; 256 Marta-Enguita (10.1016/j.jocn.2020.05.016_b0055) 2020 Wakerley (10.1016/j.jocn.2020.05.016_b0030) 2015; 52 Wu (10.1016/j.jocn.2020.05.016_b0010) 2020 Troyer (10.1016/j.jocn.2020.05.016_b0020) 2020 Virani (10.1016/j.jocn.2020.05.016_b0065) 2020 Cheyette (10.1016/j.jocn.2020.05.016_b0005) 1995; 7 Mao (10.1016/j.jocn.2020.05.016_b0025) 2020
References_xml	– start-page: 1 year: 2020 end-page: 5 ident: b0010 article-title: Nervous system involvement after infection with COVID-19 and other coronaviruses publication-title: Brain Behav Immun [Internet] – year: 2020 ident: b0020 article-title: Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms publication-title: Brain Behav Immun [Internet] – volume: 7 start-page: 125 year: 1995 end-page: 134 ident: b0005 article-title: Encephalitis lethargica: lessons for contemporary neuropsychiatry publication-title: J Neuropsychiatry Clin Neurosci – volume: 4422 start-page: 2 year: 2020 end-page: 3 ident: b0075 article-title: Correspondence publication-title: Lancet Glob Health [Internet] – year: 2020 ident: b0040 article-title: Guillain-Barré Syndrome associated with SARS-CoV-2 publication-title: N Engl J Med – volume: 31 start-page: 491 year: 2013 end-page: 510 ident: b0045 article-title: Guillain-Barré Syndrome and Variants publication-title: Neurologic Clinics – volume: 256 start-page: 1899 year: 2009 end-page: 1905 ident: b0035 article-title: A Guillain-Barré syndrome variant with prominent facial diplegia publication-title: J Neurol – year: 2020 ident: b0070 article-title: Guillain Barre syndrome associated with COVID-19 infection: a case report publication-title: J Clin Neurosci [Internet] – year: 2020 ident: b0015 article-title: ¿Es esperable que haya cuadros neurológicos por la pandemia de SARS2-CoV? publication-title: Neurología – volume: 52 start-page: 927 year: 2015 end-page: 932 ident: b0030 article-title: Isolated facial diplegia in Guillain-Barré syndrome: bifacial weakness with paresthesias publication-title: Muscle Nerve – year: 2020 ident: b0055 article-title: Síndrome de Guillain-Barré fatal tras infección por virus SARS-CoV2 publication-title: Neurología – volume: 15 start-page: 2366 year: 2016 end-page: 2378 ident: b0050 article-title: The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids publication-title: Molecular & Cellular Proteomics – year: 2020 ident: b0060 article-title: COVID-19 may induce Guillain-Barré syndrome publication-title: Rev Neurol – year: 2020 ident: b0065 article-title: Guillain-Barré Syndrome associated with SARS-CoV-2 infection publication-title: IDCases – year: 2020 ident: b0025 article-title: Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series Study publication-title: SSRN Electron J – year: 2020 ident: 10.1016/j.jocn.2020.05.016_b0015 article-title: ¿Es esperable que haya cuadros neurológicos por la pandemia de SARS2-CoV? publication-title: Neurología doi: 10.1016/j.nrl.2020.03.001 – volume: 256 start-page: 1899 issue: 11 year: 2009 ident: 10.1016/j.jocn.2020.05.016_b0035 article-title: A Guillain-Barré syndrome variant with prominent facial diplegia publication-title: J Neurol doi: 10.1007/s00415-009-5254-8 – volume: 31 start-page: 491 issue: 2 year: 2013 ident: 10.1016/j.jocn.2020.05.016_b0045 article-title: Guillain-Barré Syndrome and Variants publication-title: Neurologic Clinics doi: 10.1016/j.ncl.2013.01.005 – volume: 15 start-page: 2366 issue: 7 year: 2016 ident: 10.1016/j.jocn.2020.05.016_b0050 article-title: The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids publication-title: Molecular & Cellular Proteomics doi: 10.1074/mcp.M115.056036 – year: 2020 ident: 10.1016/j.jocn.2020.05.016_b0060 article-title: COVID-19 may induce Guillain-Barré syndrome publication-title: Rev Neurol – year: 2020 ident: 10.1016/j.jocn.2020.05.016_b0070 article-title: Guillain Barre syndrome associated with COVID-19 infection: a case report publication-title: J Clin Neurosci [Internet] doi: 10.1016/j.jocn.2020.04.062 – year: 2020 ident: 10.1016/j.jocn.2020.05.016_b0055 article-title: Síndrome de Guillain-Barré fatal tras infección por virus SARS-CoV2 publication-title: Neurología doi: 10.1016/j.nrl.2020.04.004 – start-page: 1 issue: March year: 2020 ident: 10.1016/j.jocn.2020.05.016_b0010 article-title: Nervous system involvement after infection with COVID-19 and other coronaviruses publication-title: Brain Behav Immun [Internet] – year: 2020 ident: 10.1016/j.jocn.2020.05.016_b0025 article-title: Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series Study publication-title: SSRN Electron J – year: 2020 ident: 10.1016/j.jocn.2020.05.016_b0065 article-title: Guillain-Barré Syndrome associated with SARS-CoV-2 infection publication-title: IDCases doi: 10.1016/j.idcr.2020.e00771 – volume: 4422 start-page: 2 issue: 20 year: 2020 ident: 10.1016/j.jocn.2020.05.016_b0075 article-title: Correspondence publication-title: Lancet Glob Health [Internet] – year: 2020 ident: 10.1016/j.jocn.2020.05.016_b0020 article-title: Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms publication-title: Brain Behav Immun [Internet] doi: 10.1016/j.bbi.2020.04.027 – year: 2020 ident: 10.1016/j.jocn.2020.05.016_b0040 article-title: Guillain-Barré Syndrome associated with SARS-CoV-2 publication-title: N Engl J Med doi: 10.1056/NEJMc2009191 – volume: 7 start-page: 125 issue: 2 year: 1995 ident: 10.1016/j.jocn.2020.05.016_b0005 article-title: Encephalitis lethargica: lessons for contemporary neuropsychiatry publication-title: J Neuropsychiatry Clin Neurosci doi: 10.1176/jnp.7.2.125 – volume: 52 start-page: 927 issue: 6 year: 2015 ident: 10.1016/j.jocn.2020.05.016_b0030 article-title: Isolated facial diplegia in Guillain-Barré syndrome: bifacial weakness with paresthesias publication-title: Muscle Nerve doi: 10.1002/mus.24887
SSID	ssj0009430
Score	2.5523846
Snippet	•Neurological complications related to SARS-CoV-2 are being reported around the world.•The more “rare” cases reported, causality and strong conclusions can be... We present a case of facial diplegia after 10 days of SARS-CoV-2 confirmed infection symptoms in a 61 year old patient without prior clinically relevant... We present a case of facial diplegia after 10 days of SARS-CoV-2 confirmed infection symptoms in a 61 year old patient without prior clinically relevant... • Neurological complications related to SARS-CoV-2 are being reported around the world. • The more “rare” cases reported, causality and strong conclusions can...
SourceID	pubmedcentral proquest pubmed crossref elsevier
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	230
SubjectTerms	Betacoronavirus - pathogenicity Coronavirus Coronavirus Infections - complications Coronavirus Infections - virology COVID-19 Facial diplegia Facial nerve palsy Facial Paralysis - diagnosis Facial Paralysis - etiology Facial Paralysis - virology Guillain Barré Syndrome Guillain-Barre Syndrome - diagnosis Guillain-Barre Syndrome - etiology Guillain-Barre Syndrome - virology Humans Male Middle Aged Pandemics Pneumonia, Viral - complications Pneumonia, Viral - virology SARS-CoV-2
Title	Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S0967586820311012 https://dx.doi.org/10.1016/j.jocn.2020.05.016 https://www.ncbi.nlm.nih.gov/pubmed/32410788 https://www.proquest.com/docview/2404044230 https://pubmed.ncbi.nlm.nih.gov/PMC7221378
Volume	77
WOSCitedRecordID	wos000542584900044&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1532-2653 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009430 issn: 0967-5868 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zj9MwELa6XYR4QdyUY2Uk3kJQnKN2Httql0OwQnRBfYsm19Kqm1S9tPBT-Af8Dv4Y49hO0y4sh4QqRa0b167nsz2ezHxDyFOeo54bdFM7DGLH9hnv4pzzfDtIRew5ACCyil3_DT8-FqNR-K7V-mpiYdZTXhTi_Dyc_VdRYxkKW4bO_oW46x_FAnyPQscrih2vfyT4I6is4Km0oJ8qV1iwZqXE_jSzYPl5VslljYdkUH4AL1Yy9dC4sPsw10_OraFmMpB5aMCaS_-wivrSLJVNV_Qq8KX3fmgPyo86yvCiuluHYDYYNGtQyShtKK0BwBnIDvRZWTvcW0OYlmdVqVcjuTfF4SutvrQZVChZxarjRdOMgWdW4_KqbWsmvmbjzFQZKXEZD4RKvGPWa532RS-4-qlOpj-5P90WlIVi8nxSJpLz1nUUW-sOB3e1qw9lm7JJF5c7SX62R_ZdHoSiTfZ7rw5HrzeUzn6Vyabuow7JUt6Duy39Su25eKzZ9c5tqDsnN8h1LTjaU_i6SVpZcYtcfas9MW6TLwpm1MDsGQVqQEYNyKgGGS1zugWy79-oARiFBVaVAKNNgNEmwGT9DcDukA9HhyeDl7bO42EnAXeXNstzzvwU_G6Ip20coJS7IKQqH3LwXZYA3pbgTpCHecY8cGUGHM5CEYdxwJKud5e0i7LI7hPqpQlkWQCBn6S-CADizE95GgrHC3PmpB3CzDBHiSa5l7lWppHxZpxEUjSRFE3kBBEWdYhV15kpipdL7_aM9CIzc3C7jRBql9YK6lp6himV9bf1nhiARLjuy4d5UGTlahGhJo4vPAw5HXJPAabuPY4sQ9VfdAjfglJ9g-SU3_6mGH-quOW56zKPiwf_9C8fkmubqf2ItJfzVfaYXEnWy_FifkD2-Egc6Fn0A5qz7-Q
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Facial+diplegia%2C+a+possible+atypical+variant+of+Guillain-Barr%C3%A9+Syndrome+as+a+rare+neurological+complication+of+SARS-CoV-2&rft.jtitle=Journal+of+clinical+neuroscience&rft.au=Juliao+Caama%C3%B1o%2C+David+Salom%C3%B3n&rft.au=Alonso+Beato%2C+Rub%C3%A9n&rft.date=2020-07-01&rft.pub=Elsevier+Ltd&rft.issn=0967-5868&rft.volume=77&rft.spage=230&rft.epage=232&rft_id=info:doi/10.1016%2Fj.jocn.2020.05.016&rft.externalDocID=S0967586820311012
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0967-5868&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0967-5868&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0967-5868&client=summon